Uterine cancer treatment aims to remove the disease, prevent its spread, and help patients maintain the best possible quality of life. Modern medicine offers both standard surgical and medical therapies as well as innovative approaches being tested in research centers around the world.

Understanding Treatment Goals for Uterine Cancer

When someone receives a diagnosis of uterine cancer, also called endometrial cancer when it begins in the lining of the uterus, the path forward involves careful planning and personalized care. Treatment decisions depend on many factors, including the stage of the disease, the specific type of cancer cells involved, the patient’s overall health, and whether she wishes to preserve her ability to have children in the future^[10].

The main goal of treatment is to remove the cancer completely while minimizing side effects and preserving quality of life. For early-stage disease, surgery often cures the condition. For more advanced cases, treatment may focus on controlling the cancer’s growth, relieving symptoms, and extending life^[8]. Medical societies and cancer organizations have established standard treatment guidelines based on decades of research, while scientists continue exploring new therapies through clinical trials that may offer additional hope for patients.

Uterine cancer is the most common gynecologic cancer in the United States and Canada, with most cases occurring in women who have gone through menopause^[1][4]. Fortunately, because it often causes symptoms like abnormal vaginal bleeding early on, many cases are detected at stages when treatment can be very effective. The most common form, endometrial cancer, can often be cured when found early, while uterine sarcoma, a rare type affecting the muscle of the uterus, tends to be more aggressive but accounts for only about 5 to 10 percent of all uterine cancer cases^[8].

Standard Treatment Approaches for Uterine Cancer

Surgery remains the cornerstone of treatment for most women with uterine cancer. The standard surgical procedure is called a hysterectomy, which means removing the uterus and cervix. In most cases, surgeons also remove both fallopian tubes and ovaries during the same operation. Often, the procedure includes removing lymph nodes from the pelvis and abdomen to check whether cancer has spread beyond the uterus^[12].

Modern surgical techniques have evolved significantly. Many patients can now undergo minimally invasive surgery using small incisions instead of a large abdominal cut. These approaches include standard laparoscopy or robotic-assisted surgery. Patients who receive minimally invasive surgery typically experience quicker recovery, less pain after the procedure, and fewer complications related to wound healing compared to traditional open surgery. Large clinical trials have confirmed that when patients are properly selected for minimally invasive approaches, cancer outcomes remain excellent^[12].

The surgical team performing your operation matters greatly. Experts recommend that uterine cancer patients work with a gynecologic oncologist—a doctor specially trained in treating cancers of the female reproductive system^[10]. These specialists have extensive experience with both the surgical removal of cancer and managing the complexities that can arise during and after treatment.

After surgery, additional treatments may be recommended depending on the stage and characteristics of the cancer. Radiation therapy uses high-energy rays similar to X-rays to kill any remaining cancer cells. It can be delivered externally, where a machine directs radiation beams at the pelvic area, or internally through a procedure called brachytherapy, where radioactive material is placed inside the vagina near where the cancer was located^[10][13]. Radiation therapy may be used after surgery to reduce the risk of cancer returning, or it may be offered as a primary treatment for women who cannot undergo surgery due to other health conditions.

Chemotherapy involves using special medicines to shrink or kill cancer cells throughout the body. These drugs can be taken as pills or given through a vein. Chemotherapy might be recommended after surgery to ensure all cancer cells are eliminated, to treat disease that has spread to other organs, or to manage cancer that has come back after initial treatment^[10][13]. The specific chemotherapy drugs used depend on the type and stage of uterine cancer.

Hormone therapy offers another treatment option, particularly for certain types of endometrial cancer. Since some uterine cancers grow in response to hormones like estrogen and progesterone, medications that affect these hormones can sometimes slow or stop cancer growth. Hormone therapy typically involves drugs called progestins, such as megestrol. This approach may be used for women who wish to preserve their fertility and have very early-stage disease, though it is not considered curative. Hormone therapy can also help prevent certain types of advanced or recurrent cancers from growing further^[13][14].

Side effects vary depending on which treatments are used. Surgery can cause pain, bleeding, infection, and rarely, damage to nearby organs. Removing the uterus means pregnancy is no longer possible, and removing the ovaries causes immediate menopause in women who haven’t already gone through it. Radiation therapy can cause fatigue, skin changes in the treated area, diarrhea, and bladder irritation. Chemotherapy side effects may include nausea, hair loss, fatigue, increased infection risk, and changes in appetite. Hormone therapy can cause hot flashes, weight gain, and mood changes. Your healthcare team will work with you to manage these side effects and maintain your quality of life during treatment.

Innovative Treatments Being Tested in Clinical Trials

Medical science continues advancing our understanding of uterine cancer, leading to the development of new treatment approaches being tested in clinical trials around the world. These studies aim to find therapies that are more effective, have fewer side effects, or work better for specific types of uterine cancer.

One of the most promising areas of research involves immunotherapy, which helps the body’s own immune system recognize and attack cancer cells. In 2024, the United States Food and Drug Administration approved three immune checkpoint inhibitors for treating advanced endometrial cancer: dostarlimab-gxly (brand name Jemperli), durvalumab (Imfinzi), and pembrolizumab (Keytruda)^[16]. These medications work by blocking proteins called checkpoint proteins that cancer cells use to hide from the immune system. When these proteins are blocked, the immune system can better identify and destroy cancer cells, which may slow down or stop cancer growth.

Immune checkpoint inhibitors are usually combined with chemotherapy, though they can sometimes be used alone. Not all patients benefit equally from these drugs—additional testing is often needed to determine whether a patient’s cancer has characteristics that make immunotherapy likely to work^[13][16]. Researchers are studying these treatments in various combinations and at different stages of disease to understand how to use them most effectively.

Targeted therapy represents another major area of innovation. These drugs work differently from chemotherapy because they target specific proteins or pathways that cancer cells need to survive and grow. In 2024, lenvatinib (Lenvima) became the first targeted therapy approved by the FDA specifically for endometrial cancer. Lenvatinib is a type of drug called a kinase inhibitor—it blocks proteins that cancer cells use to grow and form new blood vessels that feed tumors. This medication is typically used in combination with an immune checkpoint inhibitor like pembrolizumab to enhance effectiveness^[16].

Scientists are also investigating new uses for existing medications. Early research suggests that metformin, a drug commonly used to treat type 2 diabetes, may help prevent and treat endometrial cancer^[16]. While more studies are needed to confirm these findings, this research highlights how understanding cancer biology can reveal unexpected treatment possibilities.

Clinical trials take place in phases. Phase I trials test whether a new treatment is safe and determine the right dose to use. Phase II trials examine whether the treatment actually works against cancer and continue monitoring safety. Phase III trials compare the new treatment to current standard treatments to see if it works better or has fewer side effects. Patients participating in clinical trials gain access to cutting-edge treatments before they become widely available and contribute valuable information that helps future patients^[10].

Clinical trials for uterine cancer are being conducted at major cancer centers across the United States, Canada, Europe, and other regions. Eligibility depends on factors like the type and stage of cancer, previous treatments received, and overall health. Your healthcare team can help determine if participating in a clinical trial might be appropriate for your situation.

Understanding Diagnostic Tests That Guide Treatment

Before treatment begins, doctors need detailed information about the cancer to create the best treatment plan. This process involves several diagnostic tests. A thorough pelvic exam allows the doctor to physically check the reproductive organs. Transvaginal ultrasound uses sound waves to create images of the uterus by inserting a small probe into the vagina^[9].

To confirm cancer is present, doctors need to examine tissue under a microscope. This can be done through an endometrial biopsy, where a small tissue sample is removed from the uterine lining, or through a procedure called dilation and curettage (D&C), where the doctor scrapes tissue from the endometrium. A procedure called hysteroscopy allows direct visualization of the uterine lining using a thin tube with a camera, and tissue can be biopsied during this procedure as well^[9].

Once cancer is diagnosed, additional tests help determine if it has spread. These may include blood tests, imaging scans like CT or MRI, and examination of lymph nodes during surgery. This information determines the cancer’s stage, which is crucial for selecting the most appropriate treatment approach^[8].

Life After Uterine Cancer Treatment

Completing treatment marks the beginning of a new phase called survivorship. Follow-up care is essential, especially in the first few months and years after treatment. Regular visits with your healthcare team help ensure the cancer hasn’t returned and allow management of any long-term side effects from treatment^[13].

During treatment and recovery, patients often need support beyond medical care. Oncology nurses specialize in cancer care and can help manage symptoms and side effects. Social workers assist with practical matters like transportation to appointments and can help find support programs. Patient navigators guide patients through the healthcare system and help coordinate care. Registered dietitians provide advice on nutrition to cope with treatment side effects and maintain health^[19].

Many women find support groups helpful for connecting with others who understand what they’re going through. These groups can be found through cancer centers, community organizations, and online platforms. Counseling services can help address the emotional impact of a cancer diagnosis and treatment.

Living with or after uterine cancer means making lifestyle adjustments. Getting adequate rest, eating a nutritious diet, staying physically active as able, and taking care of your emotional health all contribute to recovery and overall well-being^[21]. It’s important to report any new or unusual symptoms to your doctor right away, as early detection of recurrence leads to better outcomes.

Most common treatment methods

• Surgery
  • Hysterectomy (removal of uterus and cervix) is the most common treatment for uterine cancer and often includes removal of fallopian tubes and ovaries
  • Lymph node removal from pelvis and abdomen helps determine if cancer has spread
  • Minimally invasive techniques using small incisions (laparoscopy or robotic surgery) offer faster recovery and less pain than traditional open surgery
  • Performed by gynecologic oncologists who specialize in reproductive system cancers
• Radiation therapy
  • External beam radiation directs high-energy rays at the pelvic area from outside the body
  • Brachytherapy places radioactive material inside the vagina near the cancer site
  • Used after surgery to kill remaining cancer cells or as primary treatment when surgery isn’t possible
  • Delivered by radiation oncologists specializing in gynecologic cancers
• Chemotherapy
  • Uses drugs taken as pills or given through veins to kill cancer cells throughout the body
  • Recommended after surgery to eliminate remaining cancer cells, treat spread disease, or manage recurrent cancer
  • Specific drugs chosen based on cancer type and stage
• Hormone therapy
  • Uses progestins like megestrol to affect hormone levels that some cancers need to grow
  • May be offered to women who wish to preserve fertility and have early-stage disease
  • Can help prevent advanced or recurrent cancers from growing
• Immunotherapy
  • Immune checkpoint inhibitors like pembrolizumab (Keytruda), dostarlimab-gxly (Jemperli), and durvalumab (Imfinzi) help the immune system attack cancer cells
  • Approved in 2024 for advanced endometrial cancer
  • Block checkpoint proteins that cancer cells use to hide from the immune system
  • Usually combined with chemotherapy, though can be used alone
• Targeted therapy
  • Lenvatinib (Lenvima) is a kinase inhibitor that blocks proteins cancer cells need to grow and form blood vessels
  • First targeted therapy approved for endometrial cancer in 2024
  • Typically used with immune checkpoint inhibitors for enhanced effectiveness